RMD Stock: ResMed Inc. Stock Price, Analysis & Insights
Get live rmd stock price $251.49, comprehensive ResMed Inc. stock analysis, charts, news, and expert forecast. Real-time rmd stock data and investment insights.
Loading chart...
Company Overview
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Company Information
- CEO
- Michael J. Farrell BE, MBA, SM
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Employees
- 9980
Contact Information
- Website
- https://www.resmed.com
- Address
- 9001 Spectrum Center Boulevard
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 25.8)
Business Model & Strategy
ResMed Inc. operates in the Medical - Instruments & Supplies industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Michael J. Farrell BE, MBA, SM, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Medical - Instruments & Supplies model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
ResMed Inc. competes in the Medical - Instruments & Supplies within the broader Healthcare. With 36.9 billion in market capitalization, the company is positioned as a established player in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the New York Stock Exchange, ResMed Inc. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating ResMed Inc. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for ResMed Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for ResMed Inc.
- ⚠Investors should consider how ResMed Inc. fits within their overall portfolio allocation
Market Cap
36.86B
P/E Ratio
25.77
Beta
0.87
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 36.86B market capitalization
- Trading Volume: 1.32M shares traded today
- Price Range: 52-week range of $199.92 - $293.81
- Exchange: Listed on New York Stock Exchange
Financial Metrics
Market Analysis for ResMed Inc.
ResMed Inc. (RMD) operates in the Medical - Instruments & Supplies industry within the Healthcare sector. With a current market capitalization of 36.86B, the company represents a significant player in its market. The stock is currently trading at $251.49 with a positivedaily change of 0.74%.
The company's 9980 employee base and presence on the New York Stock Exchangeexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of 25.77, beta of 0.87, and 52-week price range from $199.92 to $293.81when evaluating investment opportunities.
Why Invest in ResMed Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (New York Stock Exchange)
- • Experienced leadership under Michael J. Farrell BE, MBA, SM
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.